Bio Rad Laboratories Stock Performance

BIO Stock  USD 293.70  0.00  0.00%   
The firm shows a Beta (market volatility) of 1.3, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Bio Rad will likely underperform. At this point, Bio Rad Laboratories has a negative expected return of -0.082%. Please make sure to confirm Bio Rad's treynor ratio, as well as the relationship between the accumulation distribution and price action indicator , to decide if Bio Rad Laboratories performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Bio Rad Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy forward indicators, Bio Rad is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors. ...more

Actual Historical Performance (%)

One Day Return
(0.41)
Five Day Return
(3.23)
Year To Date Return
(3.79)
Ten Year Return
131.57
All Time Return
11.4 K
Last Split Factor
2:1
Last Split Date
2002-03-08
1
Bio-Rad Labs A Getting Closer To Key Technical Benchmark
11/13/2025
2
Is Bio-Rad Quietly Repositioning Its Moat Around AutomationLed Blood Diagnostics
12/15/2025
3
Stocks Generating Improved Relative Strength Bio-Rad Labs A
01/06/2026
4
ProGro BIO Releases New Independent Research
01/07/2026
5
Entry Recap Can Bio Rad Laboratories Inc Class stock surprise with quarterly results - Market Weekly Review Weekly Top Gainers Trade List - moha.gov.vn
01/12/2026
6
Hematology Analyzers Market Outlook Report 2026-2036 with Competitive Landscape, Market Share Distribution, and Investor-Focused Benchmarking
01/16/2026
7
ProGro BIO Expands Rhizol Platform with Two New Microbial Products
01/20/2026
8
Respiratory Disease Testing Market Analysis Report 2026-2031 Home-Based Diagnostics and AI Integration Drive Growth
01/22/2026
9
Transfection Reagent and Equipment Global Market Review 2021-2025 and Forecast 2026-2031 Investment Alert Biopharmas Demand for Transfection Tools Spurs Market ...
01/23/2026
10
Are these ASX small-cap stocks about to double
01/27/2026
11
What Bio-Rad Laboratories s AI-Driven Protein Assay Upgrades Mean For Shareholders
01/28/2026
Begin Period Cash Flow404.4 M
Total Cashflows From Investing Activities-160.2 M

Bio Rad Relative Risk vs. Return Landscape

If you would invest  31,143  in Bio Rad Laboratories on November 2, 2025 and sell it today you would lose (1,773) from holding Bio Rad Laboratories or give up 5.69% of portfolio value over 90 days. Bio Rad Laboratories is generating negative expected returns assuming volatility of 1.7003% on return distribution over 90 days investment horizon. In other words, 15% of stocks are less volatile than Bio, and above 99% of all equities are expected to generate higher returns over the next 90 days.
  Expected Return   
       Risk  
Considering the 90-day investment horizon Bio Rad is expected to under-perform the market. In addition to that, the company is 2.27 times more volatile than its market benchmark. It trades about -0.05 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.07 per unit of volatility.

Bio Rad Target Price Odds to finish over Current Price

The tendency of Bio Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 293.70 90 days 293.70 
roughly 97.0
Based on a normal probability distribution, the odds of Bio Rad to move above the current price in 90 days from now is roughly 97.0 (This Bio Rad Laboratories probability density function shows the probability of Bio Stock to fall within a particular range of prices over 90 days) .
Considering the 90-day investment horizon the stock has the beta coefficient of 1.3 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Bio Rad will likely underperform. Additionally Bio Rad Laboratories has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Bio Rad Price Density   
       Price  

Predictive Modules for Bio Rad

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bio Rad Laboratories. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
291.26292.96294.66
Details
Intrinsic
Valuation
LowRealHigh
264.33325.57327.27
Details
Naive
Forecast
LowNextHigh
270.86272.56274.26
Details
6 Analysts
Consensus
LowTargetHigh
316.68348.00386.28
Details

Bio Rad Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Bio Rad is not an exception. The market had few large corrections towards the Bio Rad's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Bio Rad Laboratories, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Bio Rad within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.27
β
Beta against Dow Jones1.30
σ
Overall volatility
10.26
Ir
Information ratio -0.13

Bio Rad Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Bio Rad for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Bio Rad Laboratories can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Bio Rad Laboratories generated a negative expected return over the last 90 days
The company reported the last year's revenue of 2.57 B. Reported Net Loss for the year was (1.84 B) with profit before taxes, overhead, and interest of 1.34 B.
Over 94.0% of the company shares are held by institutions such as insurance companies
Latest headline from simplywall.st: What Bio-Rad Laboratories s AI-Driven Protein Assay Upgrades Mean For Shareholders

Bio Rad Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Bio Stock often depends not only on the future outlook of the current and potential Bio Rad's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bio Rad's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding28.2 M
Cash And Short Term Investments1.7 B

Bio Rad Fundamentals Growth

Bio Stock prices reflect investors' perceptions of the future prospects and financial health of Bio Rad, and Bio Rad fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bio Stock performance.

About Bio Rad Performance

By examining Bio Rad's fundamental ratios, stakeholders can obtain critical insights into Bio Rad's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Bio Rad is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 210.22  149.92 
Return On Tangible Assets(0.24)(0.23)
Return On Capital Employed 0.03  0.03 
Return On Assets(0.23)(0.22)
Return On Equity(0.32)(0.31)

Things to note about Bio Rad Laboratories performance evaluation

Checking the ongoing alerts about Bio Rad for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bio Rad Laboratories help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Bio Rad Laboratories generated a negative expected return over the last 90 days
The company reported the last year's revenue of 2.57 B. Reported Net Loss for the year was (1.84 B) with profit before taxes, overhead, and interest of 1.34 B.
Over 94.0% of the company shares are held by institutions such as insurance companies
Latest headline from simplywall.st: What Bio-Rad Laboratories s AI-Driven Protein Assay Upgrades Mean For Shareholders
Evaluating Bio Rad's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Bio Rad's stock performance include:
  • Analyzing Bio Rad's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bio Rad's stock is overvalued or undervalued compared to its peers.
  • Examining Bio Rad's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Bio Rad's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bio Rad's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Bio Rad's stock. These opinions can provide insight into Bio Rad's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Bio Rad's stock performance is not an exact science, and many factors can impact Bio Rad's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
When determining whether Bio Rad Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Rad's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Rad Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Rad Laboratories Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bio Rad Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Will Life Sciences Tools & Services sector continue expanding? Could Bio diversify its offerings? Factors like these will boost the valuation of Bio Rad. Projected growth potential of Bio fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Bio Rad data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
(0.83)
Earnings Share
(24.01)
Revenue Per Share
92.937
Quarterly Revenue Growth
0.005
Return On Assets
0.0157
Bio Rad Laboratories's market price often diverges from its book value, the accounting figure shown on Bio's balance sheet. Smart investors calculate Bio Rad's intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Bio Rad's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Bio Rad's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Bio Rad should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Bio Rad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.